Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China · Delayed Price · Currency is CNY 10.72
-0.48 (-4.29%)
Nov 13, 2026, 3:00 PM CST
SHA:688553 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,527 | 2,403 | 2,328 | 1,782 | 1,206 | 1,306 |
Trading Asset Securities | 245.6 | 278.43 | 688.59 | 789.05 | 1,376 | 1,662 |
Cash & Short-Term Investments | 2,772 | 2,682 | 3,017 | 2,572 | 2,582 | 2,968 |
Cash Growth | 6.28% | -11.10% | 17.32% | -0.40% | -13.01% | 395.07% |
Accounts Receivable | 130.17 | 92.33 | 55.55 | 55.95 | 42.83 | 11.87 |
Other Receivables | 7.1 | 104.02 | 86.09 | 69.37 | 44.64 | 29.24 |
Receivables | 137.27 | 196.35 | 141.64 | 125.31 | 87.48 | 41.11 |
Inventory | 326.28 | 263.75 | 159.92 | 153.12 | 165.98 | 178.87 |
Prepaid Expenses | - | 0 | 0 | - | - | - |
Other Current Assets | 156.27 | 30.64 | 25.95 | 20.19 | 38 | 45.44 |
Total Current Assets | 3,392 | 3,173 | 3,344 | 2,870 | 2,873 | 3,233 |
Property, Plant & Equipment | 1,419 | 1,473 | 1,516 | 1,410 | 1,123 | 672.48 |
Long-Term Investments | 89.61 | 89.05 | 89.66 | 155.4 | 99.31 | 54.3 |
Other Intangible Assets | 56.94 | 58.41 | 60.57 | 62.09 | 63.51 | 64.01 |
Long-Term Deferred Tax Assets | 62.52 | 60.51 | 24.47 | 53.81 | 29.63 | 10.55 |
Long-Term Deferred Charges | 90.28 | 67.59 | 26.78 | 17.96 | 1.61 | - |
Other Long-Term Assets | 100.12 | 98.11 | 103.32 | 115.78 | 85.94 | 94.71 |
Total Assets | 5,211 | 5,019 | 5,166 | 4,686 | 4,277 | 4,130 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 138.86 | 146.14 | 197.03 | 133.89 | 95.52 | 59.25 |
Accrued Expenses | 38.32 | 232.6 | 235.4 | 215.31 | 47.87 | 289.79 |
Short-Term Debt | 703.26 | 624.34 | 589.08 | 426.73 | 45.04 | 13.66 |
Current Portion of Leases | 3.52 | - | 1.64 | 2.85 | 5.43 | 3.06 |
Current Income Taxes Payable | 15.94 | 0.46 | 0.24 | 11.98 | 1.27 | 10.62 |
Current Unearned Revenue | 137.57 | 106.82 | 54.33 | 27.03 | 36.87 | 35.65 |
Other Current Liabilities | 318.17 | 70.52 | 59.03 | 61.52 | 294.39 | 80.88 |
Total Current Liabilities | 1,356 | 1,181 | 1,137 | 879.32 | 526.39 | 492.91 |
Long-Term Leases | - | - | - | 2.05 | 4.62 | 3.28 |
Long-Term Unearned Revenue | 90.04 | 84.45 | 48.98 | 24.3 | 22.15 | 24.21 |
Long-Term Deferred Tax Liabilities | 3.84 | 7.21 | 6.52 | 5.54 | 5.27 | 0.6 |
Other Long-Term Liabilities | - | - | - | - | - | 50.02 |
Total Liabilities | 1,450 | 1,273 | 1,192 | 911.22 | 558.44 | 571.01 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 625.9 | 423.6 | 423.6 | 423.6 | 423.6 | 423.6 |
Additional Paid-In Capital | 2,286 | 2,489 | 2,487 | 2,485 | 2,474 | 2,473 |
Retained Earnings | 905.8 | 886.23 | 1,106 | 870.83 | 830.55 | 670.94 |
Treasury Stock | -30.02 | -30.02 | -30.02 | - | - | - |
Comprehensive Income & Other | -12.89 | -10.2 | -8.24 | -9.15 | -9.63 | -9.41 |
Total Common Equity | 3,774 | 3,758 | 3,979 | 3,771 | 3,718 | 3,558 |
Minority Interest | -13.38 | -11.25 | -5.66 | 3.83 | - | - |
Shareholders' Equity | 3,761 | 3,747 | 3,973 | 3,774 | 3,718 | 3,558 |
Total Liabilities & Equity | 5,211 | 5,019 | 5,166 | 4,686 | 4,277 | 4,130 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 706.79 | 624.34 | 590.72 | 431.63 | 55.09 | 20 |
Net Cash (Debt) | 2,066 | 2,058 | 2,426 | 2,140 | 2,527 | 2,948 |
Net Cash Growth | -2.02% | -15.19% | 13.38% | -15.31% | -14.29% | 391.73% |
Net Cash Per Share | 2.74 | 3.34 | 3.88 | 3.41 | 4.04 | 5.36 |
Filing Date Shares Outstanding | 623.76 | 623.76 | 623.76 | 626.93 | 626.93 | 626.93 |
Total Common Shares Outstanding | 623.76 | 623.76 | 623.76 | 626.93 | 626.93 | 626.93 |
Working Capital | 2,037 | 1,992 | 2,208 | 1,991 | 2,347 | 2,741 |
Book Value Per Share | 6.05 | 6.03 | 6.38 | 6.01 | 5.93 | 5.68 |
Tangible Book Value | 3,717 | 3,700 | 3,918 | 3,709 | 3,655 | 3,494 |
Tangible Book Value Per Share | 5.96 | 5.93 | 6.28 | 5.92 | 5.83 | 5.57 |
Buildings | - | 733.28 | 654.99 | 315.19 | 179.43 | 127.91 |
Machinery | - | 726.57 | 648.03 | 574.16 | 436.3 | 323.89 |
Construction In Progress | - | 414.47 | 528.71 | 768.43 | 695.81 | 365.65 |